Article
Genetic control of Group 3 (K96) capsule synthesis and complement resistance in extraintestinal pathogenic Escherichia coli.
mSphere - 28 Jul 2026
David Prince Rachael J, Bogati Rajesh, Lytle Titan, Collado Silva Andres, LeBaron Rachael A, Sorge Tiana, Olson Michael A, Wilson Eric, Erickson David L
Abstract excerpt
Extraintestinal pathogenic Escherichia coli (ExPEC) frequently produce Group 2 or 3 capsules that enhance virulence, yet genetic regulation and specific roles of Group 3 capsules remain poorly understood. Here, we demonstrate that the K96 Group 3 capsule in ExPEC strain M12 confers resistance to human serum complement. Using genetic screens, we identified phase-variable mutations in kpsC and essential roles for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
